Journals / Selçuk Tıp Dergisi / 2010 / Cilt: 26 - Sayı: 2

The causes of mortality in the department of pulmonary diseases

Göğüs hastalıkları kliniğinde mortalite nedenleri

Pages
42–45
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, we think that the knowledge about their mortality rates and the causes of mortality is useful for every clinic for their approach to the patients and considering the accompanying diseases is helpful to decrease the mortality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A retrospective study was performed to investigate the mortality among the patients hospitalized in department of chest diseases Dicle University medical school clinic.
📊
Key Findings & Data:The patients passed out in this clinic in the period from January 2004 to May 2009 were evaluated.
💡
Conclusion & Impact:In conclusion, we think that the knowledge about their mortality rates and the causes of mortality is useful for every clinic for their approach to the patients and considering the accompanying diseases is helpful to decrease the mortality.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

A retrospective study was performed to investigate the mortality among the patients hospitalized in department of chest diseases Dicle University medical school clinic. The patients passed out in this clinic in the period from January 2004 to May 2009 were evaluated. It was determined that totally 4417 patients were hospitalized (8892 hospitalization) in this period and 384 (8.6%) of them resulted in death. The mean age of the patients was 66.8±15.3 and 92 (33%) were women and 187 (67%) were men. The principal causes of their mortality were pneumonia in 92 patients (33.1%), chronic obstructive pulmonary disease (COPD) in 87 (31.2%) patients, pulmonary cancer in 52 (18.6%) patients, tuberculosis (TB) in 18 (6.5%) patients, pulmonary thromboembolism (PE) in 18 (6.5%) patients and another diseases in 12 (4,2%). When the accompanying diseases were evaluated, no additional diseases were determined in 130 (46.6%) patients; 41 patients (14.7%) had cardiac disorders, 22 patients (7.9%) had cancers outside the lungs, 18 patients (6.5%) had cor pulmonale, 17 patients (6.1%) had neurologic disorders, 15 patients (5.4%) had renal diseases, 10 patients (3.6%) had diabetes mellitus (DM), 9 patients (3.1%) had TB and 17 patients (6.1) had unclassified disorders. In conclusion, we think that the knowledge about their mortality rates and the causes of mortality is useful for every clinic for their approach to the patients and considering the accompanying diseases is helpful to decrease the mortality.

Özet

Dicle Üniversitesi Tıp Fakültesi Göğüs hastalıkları kliniğinde yatırılarak tedavi edilen hastalarda mortalite sıklığını ve nedenlerini araştırmak amacıyla retrospektif bir çalışma planlandı. Ocak 2004-Mayıs 2009 arasında bu klinikte yaşamını yitiren hastalar değerlendirildi. Bu süre içerisinde toplam 4417 hastanın yatırıldığı, (8892 yatış) bunların 384 ünün (%8.6) öldüğü saptandı. Yaş ortalaması 66.8±15.3 olan hastalardan 92’si (%33) bayan, 187’si (%67) erkekti. Ana ölüm nedenleri incelendiğinde, 92 hasta (% 33.1) pnömoni, 87 hasta (%31.2) kronik obstrüktif akciğer hastalığı (KOAH), 52 hasta (%18.6) akciğer kanseri, 18 hasta (%6.5) tüberküloz (TB) ,18 hasta (% 6.5) pulmoner tromboemboli ve 12 hasta (%4.2) diğer nedenlerle ölmüştü. Eşlik eden hastalıklar incelendiğinde 130 hastanın (%46.6) ek hastalığı olmadığı, 41 hasta (%14.7) kardiyak hastalıklar, 22 hasta (%7.9) akciğer dışı kanserler, 18 hasta (%6.5) kor pulmonale, 17 hasta (%6.1) nörolojik hastalıklar,15 hasta (%5.4) böbrek hastalıkları, 10 hasta (%3.6) diabetes mellutus DM, 9 hasta (%3.1), TB ve 17 hasta sınıflanmayan hastalıklar (%6.1) olarak saptandı. Sonuç olarak, her kliniğin kendi mortalite oranlarını ve nedenlerini bilmesinin hasta yaklaşımı açısından yararlı olacağını ve eşlik eden hastalıkların dikkate alınmasının mortaliteyi azaltmada faydalı olacağını düşünmekteyiz.

🔖

Cite This Article

SEZGİ, C., ABAKAY, A., TANRIKULU, A. Ç., ŞEN, S. H., ÇALKANAT, A. İ., ŞENYİĞİT, A. (2010). The causes of mortality in the department of pulmonary diseases. Selçuk Tıp Dergisi, Cilt: 26 - Sayı: 2, 42–45. https://ajindex.com/articles/319083

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997;349:1498-504
  2. Çımrın A. Kronik obstrüktif akciğer hastalığında son dönem. Umut S, Erdinç E (Editörler). Kronik obstrüktif akciğer hastalığı. İstanbul: Turgut Yayıncılık; 2000:273-9
  3. Bilir N. Ulusal akciğer sağlığının temel göstergeleri ve araştırma öncelikleri. Toraks Dergisi 2002; 3: 317-20 4- Toraks Derneği erişkin ve çocuklarda toplum kökenli pnömoni tanı ve tedavi rehberi, 2002. Toraks Dergisi 2002;3(Ek 3):1-15
  4. Garibaldi RA. Epidemiology of community-acquired respiratory tract infections in adults: incidence, etiology and impact. Am J Med 1985;78 (Suppl 6B):32-7
  5. Baudouin SV. The pulmonary physician in critical care 3: critical care management of community acquired pneumonia. Thorax 2002;57:267-71
  6. Feldman C, Viljoen E, Morar R et al. Prognostic factors in severe community- acquired pneumonia in patients without co-morbid illness. Respirol 2001;6:323-30
  7. Torres A, Dorca J, Zalacain R et al. Community-acquired pneumonia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:1456-61
  8. Fine MJ, Smith MA, Carson CA et al. Prognosis and outcomes of patients with community-acquired pneumonia. JAMA 1996;275:134-41
  9. Fidan A, Kıral K, Erdem İ ve ark. Toplum Kökenli Pnömonilerde Hastane Mortalitesi ve Ulusal Pnömoni Tanı ve Tedavi Rehberine Göre Değerlendirme Türk Toraks Dergisi Ağst 2005, Cilt 6, Sayı 2, Sayfa(lar) 115-121 11- Busset AS. Risk factors for COPD. Eur Respir Rev 1996;6:253-58
  10. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 1995;152:77-120
  11. Barns PJ. Managing chronic obstructive pulmonary disease. Londra: Science Press;2000 14- Siafakas NM, Bouros D. Management of acute exacerbation of chronic obstructive pulmonary disease. In:Postma DS, Siafahas NM; eds. Management of chronic obstructive pulmonary disease. ERS Monograph. Sheffield: ERS Journal Ltd Publication Office;998:264-77
  12. Aytemur Z, Göksel T, Baysak A ve ark Kronik Obstrüktif Akciğer Hastalığı Ataklarında Mortalite: Toraks Dergisi 2002;3(1):22-25 16- Halilçolar H, Tatar D, Ertuğrul G ve ark. Akkoçlu A, Öztürk C; (eds). Akciğer Kanseri: Multidisipliner Yaklaşım.Toraks Kitapları 1999;1:17-22
  13. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organis